Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2007.Q3 2007 Summary --------------- - Entered into a...

- Third quarter financial results to be released on November 7, 2007 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 22 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Mr. William C. Garriock, B.Comm, MBA, has been appointed Chairman of Cipher Pharmaceuticals' Board of Directors replacing Dr. John Mull,...

Cipher Pharmaceuticals Inc. (TSX: DND) solemnly announces the passing of Mr. Waldemar Zimmerman, Vice-Chairman and Lead Director of Cipher's Board of Directors. "It is with profound sadness that...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the U.S. Food and Drug Administration (FDA) has responded to the Company's request for formal dispute resolution of the decision to...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and six months ended June 30, 2007.Q2 2007 Summary --------------- - CIP-FENOFIBRATE...

- Second quarter financial results to be released on July 24, 2007 -Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 13 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...

Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a definitive licensing and distribution agreement with ProEthic Pharmaceuticals Inc...